Pharmacophore: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''Pharmacophore''' is a term used in the field of [[pharmacology]] to describe the features that are necessary for a [[molecule]] to interact with a specific [[biological target]] to cause a [[biological response]]. The concept was first proposed by [[Paul Ehrlich]] in the late 19th century.
== Pharmacophore ==


== Definition ==
[[File:Bzr_pm.png|thumb|right|Illustration of a pharmacophore model.]]
A pharmacophore is an abstract description of [[molecular features]] which are necessary for [[molecular recognition]] of a [[ligand]] by a biological [[macromolecule]]. In other words, it is a pattern of [[stereoelectronic]] features that is necessary to ensure the optimal [[supramolecular]] interactions with a specific biological target and to trigger (or block) its biological response.


== History ==
A '''pharmacophore''' is a theoretical model that represents the essential features of a molecule that are necessary for its biological activity. These features are responsible for the interaction of the molecule with a specific biological target, such as a [[receptor]] or [[enzyme]]. The concept of a pharmacophore is crucial in the field of [[drug design]] and [[medicinal chemistry]].
The concept of the pharmacophore was developed by [[Paul Ehrlich]] in the late 19th century. Ehrlich was the first to explain the theory of drug action in terms of [[chemical structure]] and [[biological receptor]]s. He proposed that drugs work by binding to specific receptors in the body, and that the structure of a drug determines its activity.


== Types of Pharmacophores ==
== Key Features ==
There are two main types of pharmacophores: [[ligand]]-based and [[structure]]-based. Ligand-based pharmacophores are derived from multiple [[compounds]] that are known to bind to a biological target. Structure-based pharmacophores are derived from the [[3D structure]] of the biological target.


== Applications ==
A pharmacophore model typically includes several types of features:
Pharmacophores are used in [[drug discovery]] to identify new [[chemical entities]] that could act as potential drugs. They are also used in [[medicinal chemistry]] to optimize the activity of a lead compound.
 
* '''Hydrogen bond acceptors and donors''': These are atoms or groups that can participate in hydrogen bonding, which is a key interaction in many biological processes.
* '''Hydrophobic regions''': Non-polar areas of the molecule that can interact with similar regions on the target.
* '''Aromatic rings''': Planar ring systems that can participate in π-π interactions.
* '''Charged groups''': Positively or negatively charged groups that can form ionic bonds with the target.
 
== Applications in Drug Design ==
 
Pharmacophores are used extensively in the process of [[drug discovery]] and design. By identifying the pharmacophore of a known active compound, researchers can design new molecules that mimic these features, potentially leading to new drugs with similar or improved activity.
 
=== Virtual Screening ===
 
Pharmacophore models are used in [[virtual screening]] to search large databases of compounds for those that match the pharmacophore, thus identifying potential new drug candidates.
 
=== Structure-Based Drug Design ===
 
In [[structure-based drug design]], pharmacophores are used to guide the modification of existing compounds to enhance their activity or reduce side effects.
 
== Development of Pharmacophore Models ==
 
The development of a pharmacophore model involves several steps:
 
1. '''Identification of Active Compounds''': Collecting a set of compounds known to interact with the target.
2. '''Feature Extraction''': Identifying common features among the active compounds.
3. '''Model Construction''': Building a model that represents these features in a spatial arrangement.
4. '''Validation''': Testing the model against known active and inactive compounds to ensure its predictive power.
 
== Challenges ==
 
Developing accurate pharmacophore models can be challenging due to the complexity of biological systems and the flexibility of molecules. Additionally, the presence of multiple binding modes and the dynamic nature of proteins can complicate the identification of a single pharmacophore.
 
== Related Pages ==


== See also ==
* [[Drug design]]
* [[Drug design]]
* [[Molecular modelling]]
* [[Medicinal chemistry]]
* [[Quantitative structure-activity relationship]]
* [[Molecular modeling]]
* [[Receptor (biochemistry)]]
* [[Enzyme]]


[[Category:Pharmacology]]
[[Category:Pharmacology]]
[[Category:Medicinal chemistry]]
[[Category:Medicinal chemistry]]
[[Category:Drug discovery]]
[[Category:Pharmaceutical industry]]
{{stub}}

Latest revision as of 03:39, 13 February 2025

Pharmacophore[edit]

Illustration of a pharmacophore model.

A pharmacophore is a theoretical model that represents the essential features of a molecule that are necessary for its biological activity. These features are responsible for the interaction of the molecule with a specific biological target, such as a receptor or enzyme. The concept of a pharmacophore is crucial in the field of drug design and medicinal chemistry.

Key Features[edit]

A pharmacophore model typically includes several types of features:

  • Hydrogen bond acceptors and donors: These are atoms or groups that can participate in hydrogen bonding, which is a key interaction in many biological processes.
  • Hydrophobic regions: Non-polar areas of the molecule that can interact with similar regions on the target.
  • Aromatic rings: Planar ring systems that can participate in π-π interactions.
  • Charged groups: Positively or negatively charged groups that can form ionic bonds with the target.

Applications in Drug Design[edit]

Pharmacophores are used extensively in the process of drug discovery and design. By identifying the pharmacophore of a known active compound, researchers can design new molecules that mimic these features, potentially leading to new drugs with similar or improved activity.

Virtual Screening[edit]

Pharmacophore models are used in virtual screening to search large databases of compounds for those that match the pharmacophore, thus identifying potential new drug candidates.

Structure-Based Drug Design[edit]

In structure-based drug design, pharmacophores are used to guide the modification of existing compounds to enhance their activity or reduce side effects.

Development of Pharmacophore Models[edit]

The development of a pharmacophore model involves several steps:

1. Identification of Active Compounds: Collecting a set of compounds known to interact with the target. 2. Feature Extraction: Identifying common features among the active compounds. 3. Model Construction: Building a model that represents these features in a spatial arrangement. 4. Validation: Testing the model against known active and inactive compounds to ensure its predictive power.

Challenges[edit]

Developing accurate pharmacophore models can be challenging due to the complexity of biological systems and the flexibility of molecules. Additionally, the presence of multiple binding modes and the dynamic nature of proteins can complicate the identification of a single pharmacophore.

Related Pages[edit]